Urinary tract infections: What's new?

Journal of Urology

Volumn 168, Issue 6, 2002, Pages 2351-2358

  Krieger, John N ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Drug resistance, microbial; Immunization; Pyelonephritis; Urinary tract infections; Virulence

Indexed keywords

AMPICILLIN; CEFALOTIN; CIPROFLOXACIN; COTRIMOXAZOLE; LINEZOLID; NITROFURANTOIN; OXAZOLIDINONE DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; BACTERIAL VIRULENCE; CRANBERRY; FEMALE; HEALTH BEHAVIOR; HIGH RISK POPULATION; HUMAN; IMMUNIZATION; INFECTION PREVENTION; INFECTION RISK; MALE; OUTPATIENT CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PYELONEPHRITIS; REVIEW; SELF MEDICATION; SHORT COURSE THERAPY; URINARY TRACT INFECTION;

EID: 0036896473     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(05)64145-6     Document Type: Review

References (92)

1. Guyer, D. M., Gunther, N. W., 4th and Mobley, H. L.: Secreted proteins and other features specific to uropathogenic Escherichia coli. J Infect Dis, Suppl., 183: S32, 2001
2. Johnson, J. R. and Stell, A. L.: Extended virulence genotypes of Escherichia coli strains from patients with urosepsis in relation to phylogeny and host compromise. J Infect Dis, 181: 261, 2000
3. Johnson, J. R., O'Bryan, T. T., Delavari, P., Kuskowski, M., Stapleton, A., Carlino, U. et al: Clonal relationships and extended virulence genotypes among Escherichia coli isolates from women with a first or recurrent episode of cystitis. J Infect Dis, 183: 1508, 2001
4. Schilling, J. D., Mulvey, M. A. and Hultgren, S. J.: Structure and function of Escherichia coli type 1 pili: New insight into the pathogenesis of urinary tract infections. J Infect Dis, Suppl., 183: S36, 2001.
5. Wullt, B., Bergsten, G., Samuelsson, M., Gebretsadik, N., Hull, R. and Svanborg, C.: The role of P fimbriae for colonization and host response induction in the human urinary tract. J Infect Dis, Suppl., 183: S43, 2001
6. Stapleton, A. E., Stroud, M. R., Hakomori, S. I. and Stamm, W. E.: The globoseries glycosphingolipid sialosyl galactosyl globoside is found in urinary tract tissues and is a preferred binding receptor in vitro for uropathogenic Escherichia coli expressing pap-encoded adhesins. Infect Immun, 66: 3856, 1998
7. Stapleton, A.: Host factors in susceptibility to urinary tract infections. Adv Exp Med Biol, 462: 351, 1999
8. Blum-Oehler, G., Dobrindt, U., Janke, B., Nagy, G., Piechaczek, K. and Hacker, J.: Pathogenicity islands of uropathogenic E. coli and evolution of virulence. Adv Exp Med Biol, 485: 25, 2000
9. Dozois, C. M. and Curtiss, R., 3rd: Pathogenic diversity of Escherichia coli and the emergence of 'exotic' islands in the gene stream. Vet Res, 30: 157, 1999
10. Guyer, D. M., Kao, J. S. and Mobley, H. L.: Genomic analysis of a pathogenicity island in uropathogenic Escherichia coli CFT073: Distribution of homologous sequences among isolates from patients with pyelonephritis, cystitis, and catheter-associated bacteriuria and from fecal samples. Infect Immun, 66: 4411, 1998
11. Warren, J. W., Abrutyn, E., Hebel, J. R., Johnson, J. R., Schaeffer, A. J. and Stamm, W. E.: Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Infectious Diseases Society of America (IDSA). Clin Infect Dis, 29: 745, 1999
12. Gupta, K., Scholes, D. and Stamm, W. E.: Increasing prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in women. JAMA, 281: 736, 1999
13. Gupta, K., Sahm, D., Mayfield, D. and Stamm, W. E.: Antimicrobial resistance among uropathogens that cause community-acquired urinary tract infections in women: A nationwide analysis. Clin Infect Dis, 33: 89, 2001
14. Gupta, K., Hooton, T. M. and Stamm, W. E.: Increasing antimicrobial resistance and the management of uncomplicated community-acquired urinary tract infections. Ann Intern Med, 135: 41, 2001
15. Talan, D. A., Stamm, W. E., Hooton, T. M., Moran, G. J., Burke, T., Iravani, A. et al: Comparison of ciprofloxacin (7 days) and trimethoprim-sulfamethoxazole (14 days) for acute uncomplicated pyelonephritis in women: A randomized trial. JAMA, 283: 1583, 2000
16. Blazquez, R., Menasalvas, A., Carpena, I., Ramirez, C., Guerrero, C. and Moreno, S.: Invasive disease caused by ciprofloxacin-resistant uropathogenic Escherichia coli. Eur J Clin Microbiol Infect Dis, 18: 503, 1999
17. Guyot, A., Barrett, S. P., Threlfall, E. J., Hampton, M. D. and Cheasty, T.: Molecular epidemiology of multi-resistant Escherichia coli. J Hosp Infect, 43: 39, 1999
18. Gales, A. C., Jones, R. N., Gordon, K. A., Sader, H. S., Wilke, W. W., Beach, M. L. et al: Activity and spectrum of 22 antimicrobial agents tested against urinary tract infection pathogens in hospitalized patients in Latin America: Report from the second year of the SENTRY antimicrobial surveillance program (1998). J Antimicrob Chemother, 45: 295, 2000
19. Goettsch, W., van Pelt, W., Nagelkerke, N., Hendrix, M. G., Buiting, A. G., Petit, P. L. et al: Increasing resistance to fluoroquinolones in Escherichia coli from urinary tract infections in the Netherlands. J Antimicrob Chemother, 46: 223, 2000
20. Gold, H. S.: Vancomycin-resistant enterococci: Mechanisms and clinical observations. Clin Infect Dis, 33: 210, 2001
21. Murray, B. E.: Vancomycin-resistant enterococcal infections. N Engl J Med, 342: 710, 2000
22. Fung, H. B., Kirschenbaum, H. L. and Ojofeitimi, B. O.: Linezolid: An oxazolidinone antimicrobial agent. Clin Ther, 23: 356, 2001
23. Norrby, R.: Linezolid - A review of the first oxazolidinone. Expert Opin Pharmacother, 2: 293, 2001
24. Santucci, R. A. and Krieger, J. N.: Gentamicin for the practicing urologist: Review of efficacy, single daily dosing and "switch" therapy. J Urol, 163: 1076, 2000
25. Nicolle, L. E.: Infection control in long-term care facilities. Clin Infect Dis, 31: 752, 2000
26. Nicolle, L. E.: Urinary tract pathogens in complicated infection and in elderly individuals. J Infect Dis, Suppl., 183: S5, 2001
27. Loeb, M., Bentley, D. W., Bradley, S., Crossley, K., Garibaldi, R., Gantz, N. et al: Development of minimum criteria for the initiation of antibiotics in residents of long-term-care facilities: Results of a consensus conference. Infect Control Hosp Epidemiol, 22: 120, 2001
28. Nicolle, L. E.: Urinary tract infection in long-term-care facility residents. Clin Infect Dis, 31: 757, 2000
29. Nicolle, L. E.: Asymptomatic bacteriuria-important or not? N Engl J Med, 343: 1037, 2000
30. Nicolle, L. E.: Asymptomatic bacteriuria in the elderly. Infect Dis Clin North Am, 11: 647, 1997
31. Nicolle, L. E.: Urinary tract infections in long-term-care facilities. Infect Control Hosp Epidemiol, 22: 167, 2001
32. Hooton, T. M. and Stamm, W. E.: Diagnosis and treatment of uncomplicated urinary tract infection. Infect Dis Clin North Am, 11: 551, 1997
33. Ronald, A. R., Nicolle, L. E., Stamm, E., Krieger, J., Warren, J., Schaeffer, A. et al: Urinary tract infection in adults: Research priorities and strategies. Int J Antimicrob Agents, 17: 343, 2001
34. Gupta, K. and Stamm, W. E.: Pathogenesis and management of recurrent urinary tract infections in women. World J Urol, 17: 415, 1999
35. Scholes, D., Hooton, T. M., Roberts, P. L., Stapleton, A. E., Gupta, K. and Stamm, W. E.: Risk factors for recurrent urinary tract infection in young women. J Infect Dis, 182: 1177, 2000
36. Eschenbach, D. A., Patton, D. L., Hooton, T. M., Meier, A. S., Stapleton, A., Aura, J. et al: Effects of vaginal intercourse with and without a condom on vaginal flora and vaginal epithelium. J Infect Dis, 183: 913, 2001
37. Gupta, K., Hillier, S. L., Hooton, T. M., Roberts, P. L. and Stamm, W. E.: Effects of contraceptive method on the vaginal microbial flora: A prospective evaluation. J Infect Dis, 181: 595, 2000
38. Hooton, T. M., Stapleton, A. E., Roberts, P. L., Winter, C., Scholes, D., Bavendam, T. et al: Perineal anatomy and urinevoiding characteristics of young women with and without recurrent urinary tract infections. Clin Infect Dis, 29: 1600, 1999
39. Sobota, A. E.: Inhibition of bacterial adherence by cranberry juice: Potential use for the treatment of urinary tract infections. J Urol, 131: 1013, 1984
40. Reid, G.: Potential preventive strategies and therapies in urinary tract infection. World J Urol, 17: 359, 1999
41. Ofek, I., Hasty, D. L., Abraham, S. N. and Sharon, N.: Role of bacterial lectins in urinary tract infections. Molecular mechanisms for diversification of bacterial surface lectins. Adv Exp Med Biol, 485: 183, 2000
42. Avorn, J., Monane, M., Gurwitz, J. H., Glynn, R. J., Choodnovskiy, I. and Lipsitz, L. A.: Reduction of bacteriuria and pyuria after ingestion of cranberry juice. JAMA, 271: 751, 1994
43. Fleet, J. C.: New support for a folk remedy: Cranberry juice reduces bacteriuria and pyuria in elderly women. Nutr Rev, 52: 168, 1994
44. Henig, Y. S. and Leahy, M. M.: Cranberry juice and urinary-tract health: Science supports folklore. Nutrition, 16: 684, 2000
45. Lowe, F. C. and Fagelman, E.: Cranberry juice and urinary tract infections: What is the evidence? Urology, 57: 407, 2001
46. Kontiokari, T., Sundqvist, K., Nuutinen, M., Pokka, T., Koskela, M. and Uhari, M.: Randomised trial of cranberry-lingonberry juice and Lactobacillus GG drink for the prevention of urinary tract infections in women. BMJ, 322: 1571, 2001
47. Hansson, S., Caugant, D., Jodal, U. and Svanborg-Eden, C.: Untreated asymptomatic bacteriuria in girls: I - Stability of urinary isolates. BMJ, 298: 853, 1989
48. Hansson, S., Jodal, U., Lincoln, K. and Svanborg-Eden, C.: Untreated asymptomatic bacteriuria in girls: II - Effect of phenoxymethylpenicillin and erythromycin given for intercurrent infections. BMJ, 298: 856, 1989
49. Sotolongo, J. R., Jr. and Koleilat, N.: Significance of asymptomatic bacteriuria in spinal cord injury patients on condom catheter. J Urol, 143: 979, 1990
50. Hull, R., Rudy, D., Donovan, W., Svanborg, C., Wieser, I., Stewart, C. et al: Urinary tract infection prophylaxis using Escherichia coli 83972 in spinal cord injured patients. J Urol, 163: 872, 2000
51. Roberts, J. A., Kaack, M. B. and Langermann, S.: FIMCH vaccine against a pyelonephritic E. coli. J Urol, suppl., 165: 6, abstract 27, 2001
52. Uehling, D. T., Hopkins, W. J., Balish, E., Xing, Y. and Heisey, D. M.: Vaginal mucosal immunization for recurrent urinary tract infection: Phase II clinical trial. J Urol, 157: 2049, 1997
53. Uehling, D. T., Hopkins, W. J., Beierle, L. M., Kryger, J. V. and Heisey, D. M.: Vaginal mucosal immunization for recurrent urinary tract infection: Extended phase II clinical trial. J Infect Dis, Suppl., 183: S81, 2001
54. Thankavel, K., Madison, B., Ikeda, T., Malaviya, R., Shah, A. H., Arumugam, P. M. et al: Localization of a domain in the FimH adhesin of Escherichia coli type 1 fimbriae capable of receptor recognition and use of a domain-specific antibody to confer protection against experimental urinary tract infection. J Clin Invest, 100: 1123, 1997
55. Langermann, S., Mollby, R., Burlein, J. E., Palaszynski, S. R., Auguste, C. G., DeFusco, A. et al: Vaccination with FimH adhesin protects cynomolgus monkeys from colonization and infection by uropathogenic Escherichia coli. J Infect Dis, 181: 774, 2000
56. Langermann, S. and Ballou, W. R., Jr.: Vaccination utilizing the FimCH complex as a strategy to prevent Escherichia coli urinary tract infections. J Infect Dis, Suppl., 183: S84, 2001
57. Bichler, K. H.: Urovaxom - A metaanalysis. Presented at 7th International Symposium on Clinical Evaluation of Drug Efficacy in UTI. International Society of Chemotherapy Commission for Urinary Tract Infections, Amsterdam, The Netherlands, July 1-3, 2001
58. Roberts, J. A.: Pathophysiology of bacterial cystitis. Adv Exp Med Biol, 462: 325, 1999
59. Hooton, T. M., Roberts, P. L. and Stamm, W. E.: Effects of recent sexual activity and use of a diaphragm on the vaginal microflora. Clin Infect Dis, 19: 274, 1994
60. Hooton, T. M., Scholes, D., Stapleton, A. E., Roberts, P. L., Winter, C., Gupta, K. et al: A prospective study of asymptomatic bacteriuria in sexually active young women. N Engl J Med, 343: 992, 2000
61. Raz, R., Gennesin, Y., Wasser, J., Stoler, Z., Rosenfeld, S., Rottensterich, E. et al: Recurrent urinary tract infections in postmenopausal women. Clin Infect Dis, 30: 152, 2000
62. Stamm, W. E. and Raz, R.: Factors contributing to susceptibility of postmenopausal women to recurrent urinary tract infections. Clin Infect Dis, 28: 723, 1999
63. Eriksen, B.: A randomized, open, parallel-group study on the preventive effect of an estradiol-releasing vaginal ring (Estring) on recurrent urinary tract infections in postmenopausal women. Am J Obstet Gynecol, 180: 1072, 1999
64. Hooton, T. M.: Recurrent urinary tract infection in women. Int J Antimicrob Agents, 17: 259, 2001
65. Raz, R.: Postmenopausal women with recurrent UTI. Int J Antimicrob Agents, 17: 269, 2001
66. Raz, R.: Hormone replacement therapy or prophylaxis in postmenopausal women with recurrent urinary tract infection. J Infect Dis, Suppl., 183: S74, 2001
67. Ronald, A. R. and Harding, G. K.: Complicated urinary tract infections. Infect Dis Clin North Am, 11: 583, 1997
68. Andriole, V. T.: When to do culture in urinary tract infections. Int J Antimicrob Agents, 11: 253, 1999
69. Barry, H. C., Ebell, M. H. and Hickner, J.: Evaluatinn of suspected urinary tract infection in ambulatory women: A costutility analysis of office-based strategies. J Fam Pract, 44: 49, 1997
70. Fenwick, E. A., Briggs, A. H. and Hawke, C. I.: Management of urinary tract infection in general practice: A cost-effectiveness analysis. Br J Gen Pract, 50: 635, 2000
71. Preston, S. L., Abdel-Rahman, S. M. and Nahata, M. C.: Empiric treatment of uncomplicated urinary tract infections. Ann Pharmacother, 32: 1231, 1998
72. Naber, K. G.: Treatment options for acute uncomplicated cysthtis in adults. J Antimicrob Chemother, Suppl., 46: 23, 2000
73. Schaeffer, A. J. and Stuppy, B. A.: Efficacy and safety of selfstart therapy in women with recurrent urinary tract infections. J Urol, 161: 207, 1999
74. Naber, K. G.: Which fluoroquinolones are suitable for the treatment of urinary tract infections? Int J Antimicrob Agents, 17: 331, 2001
75. Iravani, A., Klimberg, I., Briefer, C., Munera, C., Kowalsky, S. F. and Echols, R. M.: A trial comparing low-dose, short-course ciprofloxacin and standard 7 day therapy with co-trimoxazole or nitrofurantoin in the treatment of uncomplicated urinary tract infection. J Antimicrob Chemother, Suppl., 43: 67, 1999
76. Krcmery, S. and Naber, K. G.: Ciprofloxacin once versus twice daily in the treatment of complicated urinary tract infections. German Ciprofloxacin UTI Study Group. Int J Antimicrob Agents, 11: 133, 1999
77. Goto, T., Kitagawa, T., Kawahara, M., Hayami, H. and Ohi, Y.: Comparative study of single-dose and three-day therapy for acute uncomplicated cystitis. Hinyokika Kiyo, 45: 85, 1999
78. McCarty, J. M., Richard, G., Huck, W., Tucker, R. M., Tosiello, R. L., Shan, M. et al: A randomhzed trial of short-course ciprofloxacin, ofloxacin, or trimethoprim/sulfamethoxazole for the treatment of acute urinary tract infection in women. Ciprofloxacin Urinary Tract Infection Group. Am J Med, 106: 292, 1999
79. Lo Bue, A. M., Geremia, E., Castagna, C., Chisari, G. and Nicoletti, G.: Sub-MIC ciprofloxacin effect on fimbrial production by uropathogenic Escherichia coli strains. J Chemother, 11: 357, 1999
80. Naber, K. G.: Short-term therapy of acute uncomplicated cystitis. Curr Opin Urol, 9: 57, 1999
81. Hooton, T. M., Johnson, C., Winter, C., Kuwamura, L., Rogers, M. E., Roberts, P. L. et al: Single-dose and three-day regimens of ofloxacin versus trimethoprim-sulfamethoxazole for acute cystitis in women. Antimicrob Agents Chemother, 35: 1479, 1991
82. Wong, E. S., McKevitt, M., Running, K., Counts, G. W., Turck, M. and Stamm, W. E.: Management of recurrent urinary tract infections with patient-administered single-dose therapy. Ann Intern Med, 102: 302, 1985
83. Mombelli, G., Pezzoli, R., Pinoja-Lutz, G., Monotti, R., Marone, C. and Franciolli, M.: Oral vs intravenous ciprofloxacin in the initial empirical management of severe pyelonephritis or complicated urinary tract infections: A prospective randomized clinical trial. Arch Intern Med, 159: 53, 1999
84. Bailey, R. R.: Single-dose/short-term therapy in children and in pregnant women. Infection, Suppl., 22: S47, 1994
85. Bailey, R. R., Begg, E. J., Smith, A. H., Robson, R. A., Lynn, K. L., Chambers, S. T. et al: Prospective, randomized, controlled study comparing two dosing regimens of gentamicin/oral ciprofloxacin switch therapy for acute pyelonephritis. Clin Nephrol, 46: 183, 1996
86. Massry, S. G., Smogorzewski, M., Hazani, E. and Shasha, S. M.: Jewish medicine and the University of Padua: Contribution of the Padua graduate Toviah Cohen to nephrology. Am J Nephrol, 19: 213, 1999
87. Angeletti, L. R. and Cavarra, B.: The Peri ouron treatise of Stephanus of Athens: Byzantine uroscopy of the 6th-7th centuries AD. Am J Nephrol, 17: 228, 1997
88. Diamandopoulos, A. A.: Uroscopy in Byzantium. Am J Nephrol, 17: 222, 1997
89. Stamm, W. E.: Measurement of pyuria and its relation to bacteriuria. Am J Med, 75: 53, 1983
90. Hiraoka, M., Hida, Y., Tuchida, S., Tsukahara, H., Yamashita, M., Kuroda, M. et al: Diagnosis of urinary tract infection by urine microscopy using a disposable counting chamber. Scand J Clin Lab Invest, 53: 705, 1993
91. Hiraoka, M., Hida, Y., Hori, C., Tsuchida, S., Kuroda, M. and Sudo, M.: Urine microscopy on a counting chamber for diagnosis of urinary infection. Acta Paediatr Jpn, 37: 27, 1995
92. Saito, A. and Kawada, Y.: Reliability of pyuria detection method. Infection, Suppl., 22: S36, 1994